Trial Profile
Pilot Study to Assess the Antiviral Activity and Safety of Besifovir Dipivoxil 150mg and L-carnitine 660mg Compared to Tenofovir Alafenamide 25mg in Chronic Hepatitis B Patients With Nonalcoholic Fatty Liver
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Besifovir (Primary) ; Levocarnitine (Primary) ; Tenofovir alafenamide
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Ildong Pharmaceutical
- 21 Aug 2018 Planned initiation date changed from 23 Jul 2018 to 23 Sep 2018.
- 31 Jul 2018 New trial record